Morocco,South Africa,Australia,China,Hong Kong SAR
China,Japan,Korea,New
Zealand,Singapore,Thailand,Austria,Belgium,Czech
Republic,Denmark,Finland,France,Germany,Hungary,Ireland,Italy,Luxembourg,Netherlands,Norway,Poland,Portugal,Romania,Slovak
Republic,Spain,Sweden,United
Kingdom,Argentina,Chile,Mexico,Peru,Bahrain,Oman,Qatar,UAE,Canada,Puerto
Rico,United States
Ensuring certainty and efficiency in the transaction
process
Successfully completing a transaction in the healthcare
industry can be complex and challenging. We have in-depth
knowledge of healthcare regulation and handle more M&A
transactions than any other law firm. From due diligence
to post-merger integration, we take care of the corporate,
tax and regulatory aspects of healthcare transactions,
helping providers and funds to prosper.
The shared goals of any healthcare transaction can quickly
become issues and concerns, as all parties seek to balance
compliance considerations with tax planning and business
strategies. We provide guidance throughout; removing the
uncertainties of investing into or selling a healthcare
business, and facilitating an efficient transaction
process.
Consolidation in the healthcare industry looks set to
continue, driven particularly by private equity
investment. Innovative healthcare delivery models focused
on value-based care, coordinated care and other
shared-risk models continue to gain popularity. And
they’re serving as the catalyst for a number of
public company SPAC transactions and vertical integration
among payors and providers. Additionally, the use of
telemedicine, technology and artificial intelligence is
growing fast and attracting new investors and capital. We
help our clients make the most of these growth
opportunities.
In healthcare transactions, we understand the need for
innovative solutions that address the intense day-to-day
realities of the industry. Our quick, creative thinking
has often solved tricky regulatory challenges and helped
deals close successfully.
We also help with day-to-day matters arising within a
fund’s portfolio of healthcare companies. These
include negotiating and drafting employment agreements
with clinicians, enforcing non-compete restrictions,
developing Stark Law and regulatorily compliant physician
compensation incentive models, establishing joint
ventures, managing payor contracting negotiations, and
other contracting and transactional matters.
We’re leaders in the field, having handled more
M&A deals than any other law firm in the last 13
years, according to Mergermarket. We’ve also been
recognized by Pitchbook as the number one legal advisor to
investors, and one of the most active legal advisors in
several private equity sectors, including healthcare.
Where there’s opportunity for growth, we’ll
partner with you to ensure the process is seamless and
efficient.
Awards and recognition
Ranked Band 1 in Healthcare: Highly Regarded,
Chambers USA 2025
Ranked in Private Equity Buyouts: Middle-Market (up to
$500M), Legal 500 US 2025
Ranked in Healthcare: Service Providers,
Legal 500 US 2025
#1 for volume of M&A deals for 14 consecutive years,
Mergermarket 2023
#1 most active law firm for combined global deal volume,
PitchBook 2023
#1 for deal count, global league table of legal
advisors, Mergermarket 2023
Experience
When it comes to mergers and acquisitions, AKD Partners
is in an unparalleled position, having handled more
M&A deals than any other law firm. From due
diligence to post-merger integration, we deliver the
transactional resources to help your fund and its
healthcare portfolio prosper. We have handled
acquisitions and sales of substantial healthcare assets;
corporate restructurings of healthcare providers; joint
ventures and strategic alliances among providers,
physicians and payors; development of provider networks;
and structuring syndications and other securities
transactions. We are often engaged not only for the
initial practice acquisition, but also the add-on and
tuck-in acquisitions. Below please find an example of
some of the deals we have completed for our clients this
year as we continue to reimagine healthcare.
TherapeuticsMD (Nasdaq: TXMD), an innovative
healthcare company focused on developing and
commercializing novel products exclusively for women,
in its USD150 million divestiture of vitaCare
Prescription Services to GoodRx. (Nasdaq: GDRX)
SOC Telemed (Nasdaq: TLMD), the largest national
provider of acute care telemedicine, in connection
with its USD302 million public-to-private buyout by
Patient Square Capital, a leading dedicated healthcare
investment firm.
CareMax (Nasdaq: CMAX) in its USD135 million
acquisition of the Medicare value-based healthcare
business of Steward Health Care. This strategic
acquisition will enable CareMax to significantly
accelerate its growth by bringing CareMax's
best-in-class, proprietary value-based care model to
the communities in which Steward's value-based care
business operates.
Represented Lionheart Acquisition Corp. II., special
purpose acquisition company (SPAC), in its USD32.6
billion agreement to merge with MSP Recovery LLC, a
Medicaid and Medicare claims recovery company.
Following the close of the transaction, MSP Recovery
will trade on the Nasdaq under the symbol MSPR.
CareMax (Nadsaq: CMAX) in its acquisition of Advantis,
a South Florida-based healthcare provider of primary
care, pharmacy and patient transportation services.
CareMax (Nasdaq: CMAX) in its acquisition of the
assets of a leading Miami Lakes medical practice.
CareMax will use this acquisition to further expand
healthcare for Medicare-eligible beneficiaries in the
South Florida region.
ICV Partners, a leading private equity investment firm
focused on lower middle market companies, in its
acquisition of Urgent Care Group and a subsequent
merger with ICV’s portfolio company, Total
Access Urgent Care. The combined organization will
operate more than 50 healthcare clinics in four states
and provide improved scale and exposure to the rapidly
growing Southeastern US market.
Unio Health Partners (formerly Urology Partners of
America), a Triton Pacific Capital Partners portfolio
company, in its acquisition of physicians formerly
affiliated with the Skyline Urology group. The former
Skyline partners join the platform as the newly formed
Greater Los Angeles Division, the second major
division in Unio.
Fulcrum Equity Partners in its USD11 million growth
equity investment in HomeFirst Home Healthcare that
enabled the home health provider to acquire Mountain
Home Health, which has multiple locations in North
Carolina and Georgia, and BridgeWay Home Health, which
has two locations in the Atlanta area.